The UVA/Padova T1D simulator was originally designed to generate single-meal scenarios and was accepted by the U.S. Food and Drug Administration (FDA) to substitute the pre-clinical for certain insulin treatments in 2008. This evidence concerns the gene INS and type 1 diabetes mellitus.